02094nam a2200349Ia 4500001001200000003000600012005001700018007001400035008004100049040007000090043001200160074001600172086002900188099002900217110016800246245024500414260011400659300002800773336002600801337002700827338003100854490002300885500003600908500002500944533008200969650003801051650006601089776025601155776025401411810006001665999001901725ocm51301450OCoLC20170811144139.0he bmb024bbca030103s2002    dcu     b    f000 0 eng d  aMNMbengcMNMdOCLCQdOCLCFdOCLCOdOCLCQdOCLCOdOCLCQdGPOdMvI  an-us---  a1033-A (MF)0 aY 4.AP 6/2:S.HRG.107-599  aY 4.AP 6/2:S.HRG.107-5991 aUnited States.bCongress.bSenate.bCommittee on Appropriations.bSubcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.10aImpacts of stress management in reversing heart disease :bhearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Seventh Congress, second session : special hearing, May 16, 2002, Washington, DC.  aWashington :bU.S. G.P.O. :bFor sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office],c2002.  aiii, 53 pages ;c24 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aS. hrg. ;v107-599  aShipping list no.: 2003-0015-M.  aCRDP Program record.  aMicrofiche.bWashington, D.C. :cU.S. G.P.O.d2002.e1 microfiche : negative. 0aStress managementzUnited States. 0aCoronary heart diseasezUnited StatesxPsychological aspects.08iOnline version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tImpacts of stress management in reversing heart diseasew(OCoLC)85278090708iPrint version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tImpacts of stress management in reversing heart diseasew(OCoLC)513014501 aUnited States.bCongress.bSenate.tS. hrg. ;v107-599.  c261049d261049